Photo by Susan Blackburn
Michelle Meyer is an Associate Professor at Geisinger and the Geisinger Commonwealth School of Medicine, where she co-directs an interdisciplinary lab that investigates judgments and decision-making related to research, innovation, and healthcare. She is also Associate Director for Research Ethics at Geisinger, chairs Geisinger's IRB Leadership Committee, directs its Research Ethics Advice and Consulting Service, and serves on its AI Governance Committee. Finally, she is the Faculty Co-Director of the Behavioral Insights Team (BIT) in Geisinger’s Steele Institute for Health Innovation. The BIT designs, implements, and rigorously evaluates provider- and patient-facing “nudges” that aim to make healthy choices easier and also investigates acceptability of nudges to stakeholders.
Her writing has appeared in leading journals of bioethics (American Journal of Bioethics, HastingsCenter Report, Kennedy Institute of Ethics Journal), law (Harvard Law Review, Administrative Law Review), and science (Science, Nature, PNAS), as well as in popular media outlets (New York Times, Slate, Wired, Los Angeles Times, and Forbes.com). She has served on numerous boards and commissions, including National Academies study committees and working groups, an American Psychological Association blue ribbon commission, the editorial board of Advances in Methods and Practices in Psychological Science, the Board of Directors of Open Humans Foundation (formerly PersonalGenomes.org), and the Ethics and Compliance Advisory Board of PatientsLikeMe. She is a Team Scientist with Wharton's Behavior Change for Good Initiative.
Before joining Geisinger, Michelle was an Assistant Professor and Director of Bioethics Policy in the Clarkson University–Icahn School of Medicine at Mount Sinai School of Medicine Bioethics Program and Adjunct Faculty at Albany Law School; an Academic Fellow at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School; a Greenwall Fellow in Bioethics and Health Policy at The Johns Hopkins and Georgetown Universities; and a Research Fellow at the John F. Kennedy School of Government at Harvard. She earned a Ph.D. in religious studies, with a focus on applied ethics, from the University of Virginia and a J.D. from Harvard Law School, where she was an editor of the Harvard Law Review. Following law school, she clerked for Judge Stanley Marcus of the U.S. Court of Appeals for the Eleventh Circuit. She graduated summa cum laude from Dartmouth College.
Latest: Meyer et al., Objecting to experiments that compare two unobjectionable policies or treatments, PNAS (2019).
Her writing has appeared in leading journals of bioethics (American Journal of Bioethics, HastingsCenter Report, Kennedy Institute of Ethics Journal), law (Harvard Law Review, Administrative Law Review), and science (Science, Nature, PNAS), as well as in popular media outlets (New York Times, Slate, Wired, Los Angeles Times, and Forbes.com). She has served on numerous boards and commissions, including National Academies study committees and working groups, an American Psychological Association blue ribbon commission, the editorial board of Advances in Methods and Practices in Psychological Science, the Board of Directors of Open Humans Foundation (formerly PersonalGenomes.org), and the Ethics and Compliance Advisory Board of PatientsLikeMe. She is a Team Scientist with Wharton's Behavior Change for Good Initiative.
Before joining Geisinger, Michelle was an Assistant Professor and Director of Bioethics Policy in the Clarkson University–Icahn School of Medicine at Mount Sinai School of Medicine Bioethics Program and Adjunct Faculty at Albany Law School; an Academic Fellow at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School; a Greenwall Fellow in Bioethics and Health Policy at The Johns Hopkins and Georgetown Universities; and a Research Fellow at the John F. Kennedy School of Government at Harvard. She earned a Ph.D. in religious studies, with a focus on applied ethics, from the University of Virginia and a J.D. from Harvard Law School, where she was an editor of the Harvard Law Review. Following law school, she clerked for Judge Stanley Marcus of the U.S. Court of Appeals for the Eleventh Circuit. She graduated summa cum laude from Dartmouth College.
Latest: Meyer et al., Objecting to experiments that compare two unobjectionable policies or treatments, PNAS (2019).